Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
23.80
0.69 (2.99%)
At close: Oct 03, 2025, 3:59 PM
23.78
-0.08%
After-hours: Oct 03, 2025, 07:17 PM EDT
Apellis Pharmaceuticals Revenue
Apellis Pharmaceuticals reported an annual revenue of $781.37M, reflecting a 97.02% growth. For the quarter ending June 30, 2025, Apellis Pharmaceuticals generated $178.49M in revenue.
Revenue (ttm)
781.37M
Revenue Growth
97.02%
Price / Sales Ratio
5.06
Revenue / Employee
1.11M
Employees
705
Market Cap
3.01B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 781.37M | +97.02% |
| Dec 31, 2023 | 396.59M | +425.83% |
| Dec 31, 2022 | 75.42M | +13.31% |
| Dec 31, 2021 | 66.56M | -73.44% |
| Dec 31, 2020 | 250.65M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |